Sign In
Buy ELV
$388.50
-2.77 (-0.708%)
At Close: Jun 18, 2026
Elevance Health (ELV) Tops Q1 Earnings and Revenue Estimates
08:25am, Wednesday, 19'th Apr 2023
Elevance Health (ELV) came out with quarterly earnings of $9.46 per share, beating the Zacks Consensus Estimate of $9.26 per share. This compares to earnings of $8.25 per share a year ago.
Elevance Health revenue growth hurt by a $1.8B unrealized loss
07:39am, Wednesday, 19'th Apr 2023
Elevance Health (NYSE: ELV), the giant insurance company, had a strong performance in the first quarter as the number of insurance enrolments increased. Its revenue and earnings per share (EPS) were b
Elevance Health Profits Hit $2 Billion As Insurer Adds 1.3 Million Members
06:35am, Wednesday, 19'th Apr 2023
Elevance Health reported a first quarter profit of nearly $2 billion as the health insurer added more than 1 million new members.
ELV or DOCS: Which Is the Better Value Stock Right Now?
12:56pm, Thursday, 13'th Apr 2023
Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Doximity (DOCS). But which of these two stocks presents investors with the better value opportunity r
Elevance (ELV) to Divest Life & Disability Business to StanCorp
09:13am, Wednesday, 29'th Mar 2023
With the sale of the life and disability business, Elevance Health (ELV) is focusing on growing its more profitable operations.
ELV or DOCS: Which Is the Better Value Stock Right Now?
12:58pm, Tuesday, 28'th Mar 2023
ELV vs. DOCS: Which Stock Is the Better Value Option?
Elevance (ELV) Arm to Bring Virtual-First Plans to Georgia
11:29am, Tuesday, 28'th Mar 2023
The cocktail of virtual and in-person options from Elevance Health's (ELV) part of the Anthem family of brands is expected to enrich members' health experience.
Elevance Health: Reaffirmed Long-Term Target Is Reassuring
08:51pm, Monday, 27'th Mar 2023
ELV's long-term EPS growth target has been reaffirmed, with a top-line growth target of high single-digit to low double-digit growth and a margin of 5.5 to 6.5%. I believe the acquisition of BioPlus w
Here's Why You Should Retain Elevance (ELV) in Your Portfolio
12:59pm, Monday, 20'th Mar 2023
Strong local presence, improving top line, membership hike and significant new contracts in its government business poise Elevance Health (ELV) well for growth.
Dividend Champion, Contender, And Challenger Highlights: Week Of March 19
05:04am, Sunday, 19'th Mar 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Dividend Stock Watch List: Lanny's March 2023 Edition
06:22am, Saturday, 11'th Mar 2023
Dividend investing happens, whether the stock market is up or down, whether the Fed raises interest rates or lowers. It's all about buying dividend income-producing stocks – the best source of passi
Will Biden's Tax Hike Plan Extend Medicare's Life to 2050?
09:47am, Wednesday, 08'th Mar 2023
U.S. President Joe Biden's proposal is also likely to enhance Medicare's ability to negotiate prices for drugs.
7 Growth Stocks to Consider for Long-Term Portfolio Gains
11:07am, Sunday, 05'th Mar 2023
With the Federal Reserve perhaps poised to raise benchmark interest rates again, a temptation exists to avoid long-term growth stocks altogether. Should borrowing costs rise sharply, this dynamic woul
Buy This Undervalued Blue Chip Stock for Tremendous Dividend Growth
07:20am, Sunday, 05'th Mar 2023
Elevance Health is among the most dominant players in its industry. The company's dividend obligation is low.
32 Upcoming Dividend Increases Including 2 Dividend Kings
04:57pm, Thursday, 02'nd Mar 2023
All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 8.3% and a median increase of 8.1%.
